People
The Knight Cancer Institute’s Center for Experimental Therapeutics (CET) represents multidisciplinary collaborations among scientists, physicians and engineers across 博彩网站.
Leadership
The Center for Experimental Therapeutics is co-led by Sanjay Malhotra, Ph.D., and Shivaani Kummar, M.D.
-
- Shivaani Kummar, M.D., FACP
- Margaret and Lester DeArmond University Chair of Molecular Oncology
Become a member
CET membership is open to anyone at 博彩网站 with an interest in advancing drug discovery and development. Members receive periodic email communication about events, programming, news and funding opportunities.
Affiliate members
-
- Brian J. Druker, M.D.
- JELD-WEN Chair of Leukemia Research
-
- Sancy Leachman, M.D., Ph.D. (she/her)
- John D. Gray Endowed Chair for Melanoma Research
- Leachman/Cassidy Lab
-
- Nadine Mallak, M.D. (she/her)
- Nuclear Medicine and Body Radiologist
- Molecular Imaging and Therapy
-
- Stephen Roberts, M.D. (he/him)
- Robert C. Neerhout Chair of Pediatric Oncology, Division Head, Pediatric Hematology and Oncology
Farouk Al-Ajam, B.S.
M.D. Student, 博彩网站 School of Medicine
Laura Erker, Ph.D.
Director Strategic Partnerships, 博彩网站
Julia Hamilton, M.D.
Internal Medicine Resident, Clinical Oncology, 博彩网站
Jonathan Jubera, M.B.A.
Senior Project Manager, OCTRI. Biomedical Innovation Program (BIP), 博彩网站
Aditi Martin, Ph.D.
Senior Director, Collaborations and Entrepreneurship, 博彩网站
Lisa Marie Nelson, Ph.D.
Medical Student. 博彩网站 School of Medicine
H. Michael Shepard, Ph.D.
President, Co-Founder & CSO, Enosi Therapeutics
Paul Wilson, Ph.D.
Biomedical Scientist, Biological Systems Sciences Group Leader
Pacific Northwest National Laboratory